Susceptibility to highly sulphated glycosaminoglycans of human immunodeficiency virus type 1 replication in peripheral blood lymphocytes and monocyte-derived macrophages cell cultures

被引:11
作者
Bartolini, B
Di Caro, A
Cavallaro, RA
Liverani, L
Mascellani, G
La Rosa, G
Marianelli, C
Muscillo, M
Benedetto, A
Cellai, L
机构
[1] IRCCS L Spallanzani, Ist Nazl Malattie Infett, Serv Virol, I-00149 Rome, Italy
[2] CNR, Sez Roma, Ist Cristallog, I-00016 Monterotondo, Italy
[3] OPOCRIN SpA, I-41040 Modena, Italy
[4] Ist Super Sanita, Lab Igiene Ambientale, I-00161 Rome, Italy
关键词
oversulphated glycosaminoglycans; HIV; AIDS;
D O I
10.1016/S0166-3542(02)00209-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In the search for new drugs against human immunodeficiency virus type I (HIV-1), the replication Of IIIB and BaL strains, and of seven primary, isolates from AIDS patients, cultured both in peripheral blood lymphocytes (PBLs) and in monocyte-derived macrophages (MACs), was investigated in the presence of two dermatan sulphate and heparin at 10 mug/ml. The three polysaccharides effectively inhibited the replication Of IIIB in PBLs and of BaL in MACs, while producing either a slight inhibition or an unexpected large increase in the replication of the seven primary isolates, especially in MAC cultures. In one case, stimulation was found in PBLs and, at lower doses, also with BaL in MACs. Co-receptor use, adaptation to C8166 T cell line, partial sequence of the gp 120 V3 loop, variation in positive charge distribution and number of potential glycosylation sites along the V3 loop were assessed for each strain. No explanation could be found for the different susceptibility of the viruses to the polysaccharides. Their presence probably brings about both inhibitory and stimulatory effects. the final outcome depending on the virus, cells and polysaccharide. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:139 / 147
页数:9
相关论文
共 33 条
[1]   MECHANISM OF INHIBITORY EFFECT OF DEXTRAN SULFATE AND HEPARIN ON REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUS INVITRO [J].
BABA, M ;
PAUWELS, R ;
BALZARINI, J ;
ARNOUT, J ;
DESMYTER, J ;
DECLERCQ, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (16) :6132-6136
[2]   SULFATED POLYSACCHARIDES ARE POTENT AND SELECTIVE INHIBITORS OF VARIOUS ENVELOPED VIRUSES, INCLUDING HERPES-SIMPLEX VIRUS, CYTOMEGALO-VIRUS, VESICULAR STOMATITIS-VIRUS, AND HUMAN IMMUNODEFICIENCY VIRUS [J].
BABA, M ;
SNOECK, R ;
PAUWELS, R ;
DECLERCQ, E .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (11) :1742-1745
[3]  
Bjorndal A, 1997, J VIROL, V71, P7478
[4]   Binding of sindbis virus to cell surface heparan sulfate [J].
Brynes, AP ;
Griffin, DE .
JOURNAL OF VIROLOGY, 1998, 72 (09) :7349-7356
[5]   MACROPHAGE-TROPIC HUMAN-IMMUNODEFICIENCY-VIRUS ISOLATES FROM DIFFERENT PATIENTS EXHIBIT UNUSUAL V3 ENVELOPE SEQUENCE HOMOGENEITY IN COMPARISON WITH T-CELL-TROPIC ISOLATES - DEFINITION OF CRITICAL AMINO-ACIDS INVOLVED IN CELL TROPISM [J].
CHESEBRO, B ;
WEHRLY, K ;
NISHIO, J ;
PERRYMAN, S .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6547-6554
[6]   The fusion domain of HIV gp41 interacts specifically with heparan sulfate on the T-lymphocyte cell surface [J].
Cladera, J ;
Martin, I ;
O'Shea, P .
EMBO JOURNAL, 2001, 20 (1-2) :19-26
[7]  
Cullen BR., 2001, HIV SEQUENCE COMPEND
[8]   ANTIVIRAL AGENTS - CHARACTERISTIC ACTIVITY SPECTRUM DEPENDING ON THE MOLECULAR TARGET WITH WHICH THEY INTERACT [J].
DECLERCQ, E .
ADVANCES IN VIRUS RESEARCH, VOL 42, 1993, 42 :1-55
[9]   MINIMAL REQUIREMENTS FOR THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 V3 DOMAIN TO SUPPORT THE SYNCYTIUM-INDUCING PHENOTYPE - ANALYSIS BY SINGLE AMINO-ACID SUBSTITUTION [J].
DEJONG, JJ ;
DERONDE, A ;
KEULEN, W ;
TERSMETTE, M ;
GOUDSMIT, J .
JOURNAL OF VIROLOGY, 1992, 66 (11) :6777-6780
[10]   Fractions of chemically oversulphated galactosaminoglycan sulphates inhibit three enveloped viruses: human immunodeficiency virus type 1, herpes simplex virus type 1 and human cytomegalovirus [J].
Di Caro, A ;
Perola, E ;
Bartolini, B ;
Marzano, M ;
Liverani, L ;
Mascellani, G ;
Benedetto, A ;
Cellai, L .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1999, 10 (01) :33-38